PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition.
about
The code of non-coding RNAs in lung fibrosisThe Role of PI3K Isoforms in Regulating Bone Marrow Microenvironment Signaling Focusing on Acute Myeloid Leukemia and Multiple Myeloma.Idiopathic pulmonary fibrosis and cancer: do they really look similar?Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapyIdentification of sirtuin 1 as a promising therapeutic target for hypertrophic scars.Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFEmerging therapeutic interventions for idiopathic pulmonary fibrosis.Lung carcinogenesis and fibrosis taken together: just coincidence?Dual targeting of MEK and PI3K pathways attenuates established and progressive pulmonary fibrosis.Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis."Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology.Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.Evaluation of WO2013117503 and WO2013117504: the use of PI3K inhibitors to treat cough or idiopathic pulmonary fibrosis.Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.Repositioning compounds from cancer drug discovery to IPF: PI3K inhibition.AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis.Development and Characterization of an In Vitro Model for Radiation-Induced Fibrosis.A novel computational approach for drug repurposing using systems biology.Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients.
P2860
Q28386827-297F41B5-9558-44EC-990D-F98033EA75DCQ33607950-C2F8F75C-C6EA-43C4-9F44-DE68820CF9F2Q35785589-A285B497-AC66-47C9-8BA8-977A2EF85D7AQ36451560-3953CBD3-BE3C-47C1-8989-A9C5D08262E5Q36830137-7D5BE444-295E-4EA0-B2B7-6DB861B4F998Q37156395-FCFEC6D7-5FB9-4691-A0B8-325DFA7D620EQ38207153-7870B17D-247B-40E8-8FAA-961F7FC51747Q39237924-094F4C27-738D-4AB9-AF60-EF50223DEC71Q41894002-6D6B6629-5FF8-4651-877D-DF0E199C4AA5Q42482212-36576CED-9A09-4ECD-9BCB-7E2181002DADQ42594342-53B74451-6F7E-40A7-BDE8-DEC1C70D6ED3Q42680112-BD33AE7C-420A-46C8-B55B-0524BE3E251CQ43833237-91949929-F134-4E09-A8C7-B7F01E09A1D8Q47937434-CA2D1385-7F94-49A6-BF5C-2FDE2CFB836BQ48156634-58A69F97-343D-44BF-AB1A-902C4814FFB1Q48198499-45E88208-B407-45E5-B0FC-EBC1542BB2CEQ48208455-E82EA932-5B2D-4229-963C-7C3F9524F8DDQ49920680-939D1898-9DA8-4A49-80BB-CA1118E18AA0Q52657953-3F27B04B-66E1-4CFD-A66B-B70552677795Q52937788-7D5ECE01-8DA6-4D00-B92E-D429CCFD5B9AQ54977057-E1D1372C-48E6-4C50-83EF-C728B8426722
P2860
PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
PI3K p110γ overexpression in i ...... tro effects of its inhibition.
@en
PI3K p110γ overexpression in i ...... tro effects of its inhibition.
@nl
type
label
PI3K p110γ overexpression in i ...... tro effects of its inhibition.
@en
PI3K p110γ overexpression in i ...... tro effects of its inhibition.
@nl
prefLabel
PI3K p110γ overexpression in i ...... tro effects of its inhibition.
@en
PI3K p110γ overexpression in i ...... tro effects of its inhibition.
@nl
P2093
P2860
P356
P1476
PI3K p110γ overexpression in i ...... tro effects of its inhibition.
@en
P2093
Andreas Guenther
Carlo Vancheri
Debora Lo Furno
Elisa Gili
Enrico Conte
Evelina Fagone
Maria Iemmolo
Martina Korfei
Mary Fruciano
P2860
P2888
P304
P356
10.1038/LABINVEST.2013.6
P577
2013-02-25T00:00:00Z